Vivos Therapeutics Forms Death Cross, Signaling Potential Bearish Trend Ahead

Vivos Therapeutics, Inc., a microcap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a significant technical event known as a Death Cross. This occurs when a stock's short-term moving average crosses below its long-term moving average, often signaling a potential shift in market sentiment and a bearish trend.
Currently, Vivos Therapeutics shows a mixed technical outlook. The MACD indicates a bearish trend on a weekly basis, while the monthly view is mildly bullish. The Relative Strength Index (RSI) presents a bullish stance weekly but turns bearish monthly, reflecting volatility in investor sentiment. Additionally, Bollinger Bands and KST metrics suggest a mildly bearish trend in both weekly and monthly assessments.

Despite a 1.35% increase in one day, Vivos has struggled year-to-date, with a performance decline of 29.84%, contrasting sharply with the S&P 500's gain of 15.47%. Over the past year, the stock has gained 12.73%, but this is underwhelming compared to the S&P 500's 16.9% rise. Investors should closely monitor these trends, as the Death Cross may indicate further challenges ahead for Vivos Therapeutics.